rhodioloside has been researched along with honokiol in 1 studies
Studies (rhodioloside) | Trials (rhodioloside) | Recent Studies (post-2010) (rhodioloside) | Studies (honokiol) | Trials (honokiol) | Recent Studies (post-2010) (honokiol) |
---|---|---|---|---|---|
621 | 2 | 519 | 816 | 1 | 586 |
Protein | Taxonomy | rhodioloside (IC50) | honokiol (IC50) |
---|---|---|---|
Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | 1.39 | |
TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 48.8 | |
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 12.0226 | |
Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 4.2 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 2.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Buabeid, M; Dhanasekaran, M; Dwyer, D; Fabbrini, M; Fujihashi, A; Govindarajulu, M; Lynd, T; Mohanakumar, KP; Moore, T; Neel, L; Ramesh, S; Shah, K; Smith, F | 1 |
1 review(s) available for rhodioloside and honokiol
Article | Year |
---|---|
Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Animals; Biphenyl Compounds; Dietary Supplements; Drug Delivery Systems; Enzyme Inhibitors; Glucosides; Humans; Hydrazines; Indazoles; Lignans; Neuroprotection; Phenols; Sirtuin 3 | 2021 |